Search
for
Sort by
Research 751–780 of 1000+
- Morphological Changes of Meibomian Glands in Men With Benign Prostate Hyperplasia
- Re: Associations Between Variants in the Cyclooxygenase 2 Enzyme Gene (PTGS2) and Development of Benign Prostate Enlargement
- IMPACT OF LOW DOSE FINASTERIDE FOR THE TREATMENT OF ANDROGENIC ALOPECIA ON SERUM PROSTATE SPECIFIC ANTIGEN (PSA) LEVELS IN MEN PARTICIPATED IN POPULATION-BASED SCREENING FOR PROSTATE CANCER
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Serum prostate spesific antigen levels in women with androgenetic alopecia
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Risk factors for prostate cancer: a case-control study in Greece
- Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKCε without inhibiting Akt
- Doxil (Caelyx): an exploratory study with pharmacokinetics in patients with hormone-refractory prostate cancer
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Novel Anti-Prostate Cancer Curcumin Analogues That Enhance Androgen Receptor Degradation Activity
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Redefining hormone resistance in prostate cancer
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
- Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Risk factors for prostate cancer: a case‐control study in Greece
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- The influence of <i>Castanea sativa</i> Mill. flower extract on hormonally and chemically induced prostate cancer in a rat model
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia
- Terapia antiandrogénica como quimioprevención del cáncer de próstata
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Fluxactive Complete (#1 PREMIUM PROSTATE SUPPORT FORMULA) Managing Prostate Wellness And Bladder Functions!
- Identification of seven new prostate cancer susceptibility loci through a genome-wide association study